Skip to main content
. Author manuscript; available in PMC: 2020 Jul 21.
Published in final edited form as: Clin Cancer Res. 2019 Jul 12;25(20):6119–6126. doi: 10.1158/1078-0432.CCR-19-0879

Figure 1. Comparison of the ctDNA mutational profiles of SCLC at diagnosis and relapse.

Figure 1.

Panels A and B demonstrate maximum AFs and MAFs, respectively when samples are categorized by treatment status (diagnosis vs. relapse). Panels C and D demonstrate the number of mutations and amplifications respectively in diagnosis and relapse samples. Error bars represent Mean ± SEM. *, p < 0.05. ***, p<0.001. n.s = not significant.